Human monoclonal antibody derived from transchromosomic cattle neutralizes multiple H1 clades of influenza A virus by recognizing a novel conformational epitope …
Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational …
R Gao, CC Sreenivasan, Z Sheng, BM Hause… - Journal of …, 2020 - europepmc.org
Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
[HTML][HTML] Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel …
R Gao, CC Sreenivasan, Z Sheng, BM Hause… - Journal of …, 2020 - ncbi.nlm.nih.gov
Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational …
R Gao, CC Sreenivasan, Z Sheng… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Influenza remains a global health risk and challenge. Currently, neuraminidase (NA)
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …
inhibitors are extensively used to treat influenza, but their efficacy is compromised by the …